Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants사설: SARS-CoV-2에 대한 단백질 기반 보조제 Nuvaxovid(NVX-CoV2373) Novavax 백신의 첫 번째 승인은 백신 흡수를 증가시키고 바이러스 변이체로부터 면역 보호를 제공할 수 있음Editorial Published on 2022-03-012022-09-11 Journal: Medical science monitor : international medical jo [Category] SARS, 변종, 신약개발, [키워드] approval component editorial elicit EMA epitope Epitopes European European Commission European Medicines Agency full-length S protein Great Britain Healthcare Products Regulatory Agency immune response immune responses increase individual Matrix-M Medicine Medicines MHRA Novavax NVX-CoV2373 product PROTECT protection Protein recommendation S protein SARS-CoV-2 shelf life temperature the S protein the SARS-CoV-2 the vaccine union uptake Vaccine Viral variants [DOI] 10.12659/MSM.936523 PMC 바로가기 [Article Type] Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients사설: 입원하지 않은 환자의 SARS-CoV-2 감염에 대한 경구용 항바이러스제 치료 현황Editorial Published on 2022-01-012022-09-11 Journal: Medical science monitor : international medical jo [Category] SARS, 변종, 신약개발, 진단, 치료제, [키워드] administration antiviral drug antiviral drug treatment antiviral drugs approval approved bamlanivimab can be used Casirivimab children Community community setting costly COVID-19 current drug drug treatments early stage early stages editorial effective Emergency use authorization etesevimab EUA FDA healthcare facility Healthcare Products Regulatory Agency Hospitalization Imdevimab increased risk intravenous Intravenous administration Medicine Medicines MHRA Mild Moderate COVID-19 molnupiravir neutralizing monoclonal antibodies Nirmatrelvir oral Paxlovid positive priority product progression Regulatory Remdesivir Ritonavir SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test SARS-CoV-2 virus severe COVID-19 status the SARS-CoV-2 virus therapeutic Treatment variants of concern [DOI] 10.12659/MSM.935952 PMC 바로가기 [Article Type] Editorial
Editorial Comment: Efficiency and satisfaction with telephone consultation of follow-up patients in neuro-urology: Experience of the COVID-19 pandemicUpdate in Urology Published on 2021-12-212022-10-29 Journal: International Brazilian Journal of Urology : official journal of the Brazilian Society of Urology [Category] Coronavirus, SARS, [키워드] COVID-19 pandemic editorial experience Follow-up Patient Satisfaction [DOI] 10.1590/S1677-5538.IBJU.2022.01.04 PMC 바로가기 [Article Type] Update in Urology
Editorial for the COVID-19 special issue of PHCRDEditorial Published on 2021-12-032022-10-28 Journal: Primary Health Care Research & Development [Category] Coronavirus, SARS, [키워드] COVID-19 editorial [DOI] 10.1017/S1463423621000761 PMC 바로가기 [Article Type] Editorial
Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza VirusesEditorial Published on 2021-10-042023-06-14 Journal: Medical science monitor : international medical jo [Category] MERS, SARS, [키워드] COVID-19 editorial Epidemiology Influenza, Human Pandemics SARS-CoV-2 [DOI] 10.12659/MSM.934949 PMC 바로가기 [Article Type] Editorial
Editorial on COVID-19 Vaccine, Variants and New WavesCOVID-19 백신, 변종 및 새로운 물결에 대한 편집Editorial Published on 2021-10-012022-09-11 Journal: Journal of infection and public health [Category] SARS, 변종, [키워드] COVID-19 editorial New Wave [DOI] 10.1016/j.jiph.2021.09.017 PMC 바로가기 [Article Type] Editorial
Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19사설: 1형 인터페론을 포함한 면역 체계의 구성 요소에 대한 자가항체 및 심각한 COVID-19의 위험Editorial Published on 2021-09-202022-09-11 Journal: Medical science monitor : international medical jo [Category] SARS, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Asymptomatic individuals autoantibodies autoantibody chemokines Clinical outcome clinical outcomes clinical risk Clinical studies clinical study complement complement components component components coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 Cytokines editorial identify IFNs immune system Including Infection interferons marker Patient patients with SARS-CoV-2 predict recent finding respiratory risk risk factor Risk factors SARS-CoV-2 SARS-COV-2 infection severe acute respiratory syndrome Coronavirus severe COVID-19 symptomatic System type 1 interferon type 1 interferons [DOI] 10.12659/MSM.934766 PMC 바로가기 [Article Type] Editorial
Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy사설: COVID-19 백신에 대한 최초의 완전한 규제 승인, BNT162b2 Pfizer-BioNTech 백신 및 공중 보건 정책에 대한 실제 영향Editorial Published on 2021-09-062022-09-11 Journal: Medical science monitor : international medical jo [Category] 변종, [키워드] accelerated acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration age approval approvals approved BNT162b2 booster dose coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 pandemic COVID-19 vaccine drug editorial Emergency use authorization EUA FDA food immunocompromised individual immunocompromised individuals implication include increased risk individual Older Pfizer-BioNTech Policy Prevent Public public health receive reduce Regulatory SARS-CoV-2 severe acute respiratory syndrome Coronavirus severe COVID-19 severity US FDA Vaccine Vaccine development variants of concern [DOI] 10.12659/MSM.934625 PMC 바로가기 [Article Type] Editorial
Spotlight on COVID-19: eighteen months onCOVID-19에 대한 스포트라이트: 18개월 동안Editorial Published on 2021-09-012022-09-11 Journal: The Febs Journal [Category] SARS, 변종, [키워드] Antiviral antiviral therapy article COVID-19 COVID-19 vaccine COVID-19 vaccines Critical editorial highlight immune system improvement issue journal organs Perspective SARS-CoV-2 Stage the disease therapy treating COVID-19 Vaccine variants variants of SARS-CoV-2 variety Virus-host interactions [DOI] 10.1111/febs.16167 PMC 바로가기 [Article Type] Editorial
Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021사설: 코로나19 팬데믹: CONSERVE 2021을 포함하여 정상 참작이 가능한 상황으로 인해 중요한 수정 사항이 포함된 임상 시험 보고Editorial Published on 2021-08-302022-09-11 Journal: Medical science monitor : international medical jo [Category] SARS, 임상, [키워드] Analysis clinical clinical trial clinical trials CONSORT COVID-19 COVID-19 pandemic dataset Diseases Drug development editorial feasibility implication IMPROVE include Including Infectious diseases investigators Modification modifications occur oncology other infectious diseases randomized clinical trial RCT RCTs reduce Reporting SARS-CoV-2 vaccine SPIRIT Sponsor Standard Trial trial protocol [DOI] 10.12659/MSM.934514 PMC 바로가기 [Article Type] Editorial